Sagimet Biosciences Inc.SGMTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+119.1%
5Y CAGR+187.1%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+119.1%/yr
Annual compound
5Y CAGR
+187.1%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
195x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.85M-34.2%
2024$8.89M+210.3%
2023$2.86M+415.1%
2022$556000.00+176.9%
2021$-723000.00-2510.0%
2020$30000.00+129.4%
2019$-102000.00-